Stem Cell Mobilization - CBMTG

More documents

Recommendations

Info

Cost Effective Use of Plerixafor • Maximize likelihood of successful mobilization • Minimize total costs of mobilization
QUESTIONS • Can plerixafor use be adapted to use it only in patients who need it for stem cell mobilization? • Can patients who need G only vs P+G be identified? • Is patient adapted plerixafor + growth factors (P+G) as effective as chemotherapy + growth factors (C+G)? • What is the quality of the stem cell graft mobilized by P+G vs C+G? • Does C+G mobilization add antineoplastic value?
Page 1 and 2: Stem Cell Mobilization: Patient Spe
Page 3 and 4: SDF-1 CXCR4 Interaction
Page 5: Plerixafor • US FDA approval Dec.
Page 9 and 10: Strategy 2 : Plerixafor for patient
Page 11 and 12: Decision based on actual mobilizati
Page 13 and 14: Cost-Effective Use of Plerixafor fo
Page 15 and 16: Projected number of daily apheresis
Page 17 and 18: MUSC Algorithm Yes- end of collecti
Page 19 and 20: Algorithm Effectively Guides Plerix
Page 21 and 22: Comparison Between MUSC Algorithm (
Page 23 and 24: MUSC Algorithm (MA) vs CY Mobilizat
Page 25 and 26: Median time from mobilization to tr
Page 27 and 28: Summary • The MUSC Algorithm (MA)
Page 29 and 30: Hematopoietic Graft Composition Acc
Page 31 and 32: Future Questions • Is peg-filgras
Page 33: Stem Cell Mobilization: Patient Spe

Stem Cell Mobilization - CBMTG

Create successful ePaper yourself

Delete template?

Save as template?